Analysis of Cytokine and Cytokine Receptor Production by Human Dendritic Cells

  • Victoria L. Calder
  • Timothy C. R. Prickett
  • Judith L. McKenzie
  • Derek N. J. Hart
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 329)


Dendritic cells (DC) have a unique ability to stimulate a primary T lymphocyte response. The presence of adhesion molecules on DC1 promotes the association of DC with T lymphocytes and the MHC antigen-peptide complex on DC triggers the responding T lymphocyte TCR (signal I). It is clear that additional cellular properties of the DC (signal II), as well as signalling via the adhesion molecules, are crucial to its function as a specialist antigen presenting cell (APC). 2 The nature of the DC co-stimulatory signal II remains unexplained but the possibility that DC produce cytokines such as IL-13 or IL-6, 4 which activate T lymphocytes, has been suggested. Convincing evidence that DC produce cytokines has not been forthcoming5,6 but it is clear that exogenous cytokines such as IL-17 and GM-CSF8 do impact on DC. These effects may be considered as a third signal involved in T cell activation (regulated by CD45) which primes DC to maximise their APC function.9


Human Dendritic Cell Human Tonsil Blood Dendritic Cell Antigen Present Cell Function Beta mRNA 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    T. C. R. Prickett, J. L. McKenzie and D. N. J. Hart, Adhesion molecules on human tonsil dendritic cells, Transplantation, 53: 4831 (1992).CrossRefGoogle Scholar
  2. 2.
    D. L. Mueller, M. K. Jenkins, and R. H. Schwartz, Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy, Ann. Rev. Immunol. 7: 445 (1989).CrossRefGoogle Scholar
  3. 3.
    S. B. Mizel, Interleukin 1 and T cell activation, Immunol. Today. 8: 330 (1987).CrossRefGoogle Scholar
  4. 4.
    T. Kishimoto, The biology of interleukin-6, Blood. 74: 1 (1989)Google Scholar
  5. 5.
    J. L. McKenzie, T. C. R. Prickett and D. N. J. Hart, Human dendritic cells stimulate allogeneic T cells in the absence of interleukin 1, Immunology. 67: 290 (1989).PubMedGoogle Scholar
  6. 6.
    N. Bhardwaj, U. Santhanam, L. L. Lau, S. B. Tatter, J. Ghrayeb et al, IL-l/IFN-beta2 in synovial effusions of patients with rheumatoid arthritis and other arthritides, J. Immunol. 143: 2153 (1989).PubMedGoogle Scholar
  7. 7.
    S. L. Koide, K. Inaba and R. M. Steinman, Interleukin 1 enhances T-dependent immune responses by amplifying the function of dendritic cells, J. Exp. Med. 165: 515 (1987).PubMedCrossRefGoogle Scholar
  8. 8.
    K. Inaba, R. M. Steinman, M. Witmer Pack, H. Aya, M. Inaba, T. Sudo, S. Wolpe and G. Schuler, Identification of prolierating dendritic cell precursors in mouse blood, J. Exp. Med. 175: 1175 (1992).CrossRefGoogle Scholar
  9. 9.
    T. C. R. Prickett and D. N. J. Hart, Anti-leucocyte common (CD45) antibodies inhibit dendritic cell stimulation of CD4 and CD8 T lymphocyte proliferation, Immunology. 69: 250 (1990).PubMedGoogle Scholar
  10. 10.
    M. J. Dallman, R. A. Montgomery, C. P. Larsen, A. Wanders and A. F. Wells, Cytokine gene expression analysis using Northern blotting, polymerase chain reaction and in-situ hybridization, Immunol Rev. 119: 163 (1991).PubMedCrossRefGoogle Scholar
  11. 11.
    J. E. Sims, R. B. Acres, C. E. Grubin, C. J. McMahan, J. M. Wignall et al, Cloning the interleukin 1 receptor from human T cells, Proc. Natl. Acad. Sci USA. 86: 8946 (1989).PubMedCrossRefGoogle Scholar
  12. 12.
    C. J. McMahan, J. L. Slack, B. Mosley, D. Cosman, S. D. Lupton et al, A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types, EMBO.J. 10: 2821 (1991).PubMedGoogle Scholar
  13. 13.
    C. A. Dinarello, R. C. Thompson, and R. C. Brocking, IL-1 interleukin 1 receptor antagonist in vivo and in vitro, Immunol. Today. 12: 404 (1991).PubMedCrossRefGoogle Scholar
  14. 14.
    N. A. Thornberry, H. G. Bull, J. R. Calaycay, R. T. Chapman, A. D. Howard et al, A novel heterodimeric cysteine protease is required for interleukin 1B processing in monocytes, Nature. 356: 768 (1992).PubMedCrossRefGoogle Scholar
  15. 15.
    K. W. Mclntyre, G. J. Stepan, K. D. Kolinsky, W. R. Benjamin, J. M. Plozinski et al, Inhibition of interleukin (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody, J. Exp. Med. 173: 931 (1991).CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1993

Authors and Affiliations

  • Victoria L. Calder
    • 1
  • Timothy C. R. Prickett
    • 1
  • Judith L. McKenzie
    • 1
  • Derek N. J. Hart
    • 1
  1. 1.Haematology DepartmentChristchurch HospitalChristchurchNew Zealand

Personalised recommendations